Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma
出版年份 2017 全文链接
标题
Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 114, Issue 17, Pages 4300-4305
出版商
Proceedings of the National Academy of Sciences
发表日期
2017-04-12
DOI
10.1073/pnas.1617709114
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cardiolipins Are Biomarkers of Mitochondria-Rich Thyroid Oncocytic Tumors
- (2016) Jialing Zhang et al. CANCER RESEARCH
- Reliable Entity Subtyping in Non-small Cell Lung Cancer by Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry on Formalin-fixed Paraffin-embedded Tissue Specimens
- (2016) Mark Kriegsmann et al. MOLECULAR & CELLULAR PROTEOMICS
- Lipid and metabolite profiles of human brain tumors by desorption electrospray ionization-MS
- (2016) Alan K. Jarmusch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metabolic pathways in T cell activation and lineage differentiation
- (2016) Luís Almeida et al. SEMINARS IN IMMUNOLOGY
- Pancreatic Cancer Surgical Resection Margins: Molecular Assessment by Mass Spectrometry Imaging
- (2016) Livia S. Eberlin et al. PLOS MEDICINE
- Activation of MEK1/2-ERK1/2 signaling during NNK-induced lung carcinogenesis in female A/J mice
- (2016) Keiko Yamakawa et al. Cancer Medicine
- Rapid Detection of Necrosis in Breast Cancer with Desorption Electrospray Ionization Mass Spectrometry
- (2016) Alessandra Tata et al. Scientific Reports
- Deregulated Myc Requires MondoA/Mlx for Metabolic Reprogramming and Tumorigenesis
- (2015) Patrick A. Carroll et al. CANCER CELL
- Increased phosphorylation of ERK1/2 is associated with worse chemotherapeutic outcome and a poor prognosis in advanced lung adenocarcinoma
- (2015) Ichiro Tsujino et al. Medical Molecular Morphology
- SREBP maintains lipid biosynthesis and viability of cancer cells under lipid- and oxygen-deprived conditions and defines a gene signature associated with poor survival in glioblastoma multiforme
- (2015) C A Lewis et al. ONCOGENE
- MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism
- (2015) Emelyn H. Shroff et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combined targeting of EGFR/HER promotes anti-tumor efficacy in subsets of KRAS mutant lung cancer resistant to single EGFR blockade
- (2015) Ijeoma Adaku Umelo et al. Oncotarget
- In situ biomarker discovery and label-free molecular histopathological diagnosis of lung cancer by ambient mass spectrometry imaging
- (2015) Tiegang Li et al. Scientific Reports
- MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells
- (2015) Akriti Kharbanda et al. Oncotarget
- Alteration of the lipid profile in lymphomas induced by MYC overexpression
- (2014) L. S. Eberlin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Application of desorption electrospray ionization mass spectrometry imaging in breast cancer margin analysis
- (2014) David Calligaris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Increased NQO1 but Not c-MET and Survivin Expression in Non-Small Cell Lung Carcinoma with KRAS Mutations
- (2014) Ahmet Yilmaz et al. International Journal of Environmental Research and Public Health
- Real-time nanoscale proteomic analysis of the novel multi-kinase pathway inhibitor rigosertib to measure the response to treatment of cancer
- (2013) Alice C Fan et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress
- (2013) R. M. Young et al. GENES & DEVELOPMENT
- Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
- (2013) Jaekyoung Son et al. NATURE
- MYC, Metabolism, Cell Growth, and Tumorigenesis
- (2013) C. V. Dang Cold Spring Harbor Perspectives in Medicine
- Different fatty acid metabolism effects of (−)-Epigallocatechin-3-Gallate and C75 in Adenocarcinoma lung cancer
- (2012) Joana Relat et al. BMC CANCER
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
- (2012) Haoqiang Ying et al. CELL
- KRAS Mutations in Lung Cancer
- (2012) Niki Karachaliou et al. Clinical Lung Cancer
- Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth
- (2011) D. Gaglio et al. Molecular Systems Biology
- Fatty acid synthase as a potential therapeutic target in cancer
- (2010) Richard Flavin et al. Future Oncology
- Clinical Relevance of KRAS in Human Cancers
- (2010) Sylwia Jančík et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- A concise review of mass spectrometry imaging
- (2010) Erika R. Amstalden van Hove et al. JOURNAL OF CHROMATOGRAPHY A
- Glutamine addiction: a new therapeutic target in cancer
- (2010) David R. Wise et al. TRENDS IN BIOCHEMICAL SCIENCES
- Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens
- (2009) Alice C Fan et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started